Ascendis Pharma A/S (ASND) Earnings Date & Reports
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients... Show more
ASND is expected to report earnings to rise 129.69% to -147 cents per share on May 21
Q1'25
Est.
$-1.47
Q4'24
Beat
by $0.34
Q3'24
Missed
by $0.18
Q2'24
Missed
by $0.45
Q1'24
Missed
by $0.82
The last earnings report on February 12 showed earnings per share of -63 cents, beating the estimate of -98 cents. With 53.70K shares outstanding, the current market capitalization sits at 9.01B.